Inhibition of COMMD1 expression stimulated the growth of tumor cells in lung cancer (69), neuroblastoma (79), head and neck squamous cell carcinoma (78), and prostate cancer (76). This evidence concerns the gene COMMD1 and head and neck squamous cell carcinoma.